Bangalore: In a first for Asia's bioscience industry, India's leading biotech company, Biocon has started an academy to ...
Singapore: There must have been many Indian prime ministers who have visited Australia before. But this one by the curre...
Singapore: The new pharma policy implemented in India last month led to many media reports of shortage of essential medi...
Singapore: The discussion was led by Ms Suneela Thatte, president, ISCR, and Dr Bapsy, senior consultant and head of dep...
Singapore: The Japanese owners of Ranbaxy Laboratories, drug major Daiichi Sankyo has accused the Singh brothers, former...
Singapore: The Indian Government has said that it would continue to levy import duties on Chinese analgesic API paraceta...
Singapore: Biopharmaceutical manufacturer Hospira has initiated a voluntary recall of one lot of Aminosyn, an amino acid...
Bangalore: Prior to this, he served as a faculty at NII in the area of Chemical and Systems Biology. Dr Gokhale holds a...
Mumbai: India-based Aurobindo Pharma intends to acquire Actavis' generics commercial operations in seven markets in West...
Singapore: Global medical device company St Jude Medical launched Ilumien PCI Optimization System as a treatment option ...
Singapore: Bengaluru, India, will be the first Asian city to house a science gallery, designed on the model pioneered at...
An estimated 1.5 million patients undergo diagnostic tests for Mycobacterium tuberculosis in India every year and this n...
Singapore: A Kerala-based company, Arjuna Natural Extracts, has made headlines by securing the US patent for its unique ...
Singapore: Scientists at the Indian Institute of Technology- Bombay, India have developed a unique membrane that can eff...
Singapore: Dublin headquartered generic drugmaker Actavis has now been caught in a legal tangle after Indian drug major ...
The vaccines sector within the BioPharma space witnessed a continued growth in 2011-12. Haffkine Biopharmaceutical and S...
New Delhi: The 'International Symposium on Accelerating India's Response to Research for a Preventive HIV Vaccine', whic...
New Delhi: In yet another blow to multinational companies operating in India, the Intellectual Property Appellate Board ...
